Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 13, 2023
Event: Results of the Annual Meeting of Stockholders held virtually on December 13, 2023.
Key Financial Metrics
This filing is a current report regarding corporate governance and voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
The Annual Meeting saw 3,052,019 shares voted, representing approximately 40.87% of the 7,466,772 shares outstanding as of the October 20, 2023 record date. All proposals submitted were approved.
- Proposal 1 (Director Election): All five nominees (Stephen Boyages, Lawrence Fisher, Jonathan Hurd, Jason Isenberg, Christopher Towers) were elected. Each received approximately 1.55 million votes "For" and approximately 206,000 votes "Withheld."
- Proposal 2 (Reverse Stock Split): Approved. Stockholders authorized an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-12. The Board retains discretion to set the exact ratio without further stockholder approval. Votes: 2,456,199 For; 590,016 Against.
- Proposal 3 (2019 Plan Amendment): Approved. The 2019 Long Term Incentive Plan was amended to increase authorized shares by 1,475,000 and raise the annual award limit for non-employee directors to 15,000 shares. Votes: 1,515,129 For; 235,051 Against.
- Proposals 4 & 5 (Adjournment Authority): Approved. The Company was authorized to adjourn the meeting if necessary to solicit additional proxies for Proposals 2 and 3.
Guidance, Outlook, and Risks
This filing does not contain management commentary, financial guidance, or outlook. The primary operational implication is the authorization of a reverse stock split, which is typically undertaken to meet listing requirements or improve marketability, though the specific ratio remains undetermined.
Investor Verification Checklist
- Verify the specific reverse stock split ratio once announced by the Board of Directors, as the filing only authorizes a range (1-for-2 to 1-for-12).
- Review the Definitive Proxy Statement filed on November 16, 2023, for detailed background on the director nominees and the rationale for the stock split and plan amendments.
- Monitor subsequent filings for the effective date of the reverse stock split and the updated share count.
- Check the amended 2019 Long Term Incentive Plan (Exhibit 10.1) for specific terms regarding the increased share authorization.